Healthcare Company

Pro-GeneX, LLC

To find out if this company and others are accepting funding, .

Funding Goal
Funding Raised So Far
Funding Commitments
Funding Remaining
Funding Type
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Company Overview


Pro-Genex is a marketer of pharmacogenetic testing based at Georgia Tech, in Atlanta, Georgia. Our combined genetic testing/consulting services help Acute-care and Long Term Post Acute Care operators maximize the information from test results.

Read More
lock icon

Unlock Company Profile

Sign up now to unlock full company profiles and access financials, investor documents, and engage companies.

Business Summary


Company Age 8 years, 8 months
Employees 4
Sub-Industry Medical Laboratories & Research
Prior Year Revenue
Current Year Revenue
Next Year Revenue

Products/Services


Pharmacogenetic Testing

Our genetic test products evaluate the Cytochrome P450 system in the body. This process is called Pharmacogenetic testing (PGX). The test determines if the genes related to this system are causing the body to express normal amounts of enzymes used in the metabolism of drugs. Abnormalities in this system are common, resulting in non-standard enzyme expression.
Pharmacogenetic testing holds the promise of assisting physicians and patients in selecting the right medication and the right dosage level at the outset of treatment, minimizing the risk of adverse drug events (ADRs) and maximizing outcomes. By knowing an individual’s specific metabolism of specific medications, physicians can make adjustments to dosage early on, or even choose a different medication.. The tests are FDA approved and have reimbursement from CMS and most private insurers. Our lab handles all billing so there is no added administrative burden to the client.

Management


Robert Rupard
Chief Executive Officer
Robert Rupard

From 2010 until early 2014 he served as Chief Operating Officer for Sensiotec, Inc., a Georgia Tech-based medical device firm. He was responsible for managing all research, implementation, deployment and training services for beta sites, clinical trials and managing day-to-day operations.

Prior to that, he was Founder and Chief Executive Officer / Director of Operations for Wings Air, a 75-employee, regional commuter airline that operated 10 aircraft in five states, provided scheduled service into Hartsfield Jackson International Airport, and conducted over 125 daily operations seven days a week. He was responsible for initiating gate operations at Hartsfield Jackson Airport, successfully negotiating changes in the airport security plan and establishing a new record for regulatory approval and airline conversion in the commuter industry, achieving commuter airline status with the Federal Aviation Administration and the U.S. Department of Transportation in less than 100 days.

Chief Science/Scientist
Shean Phelps, MD

Dr. Phelps is our Chief Medical Officer, largely responsible for development efforts and clinician training.

Director Operations
Leesa Gillen

Leesa is our director of clinical implementation and responsible for clinician training during inservice meetings at Long Term Care operators as well as Acute Care facilities.

To find out if this company and others are accepting funding, .

Funding Goal
Funding Raised So Far
Funding Commitments
Funding Remaining
Funding Type
Pre-Money Valuation
Investor Ownership
Interest / Dividend
Previous Funding

Documents


Contact


Pro-GeneX, LLC

Atlanta, GA 30308, US

Top 10 Tips for Entrepreneurs Seeking Funding

Users who follow these tips increase their fundraising odds substantially.

  • Complete Your Funding Profile
    • Complete your funding profile with all sections filled, including your products and services, a complete management team with headshots, and slideshow with product images.
  • Complete a Business Plan
    • Complete a Business Plan in EquityNet and refine your financial projections using the benchmarking alerts in the Business Plan Analysis report.
  • Upload Important Investment Documents
    • Upload and present any other important investment documents such as pitch decks, financial statements, and offering materials.
  • Use EquityNet Crowdcast
    • Use the EquityNet Crowdcast system to automatically email invitations to your contacts in order to build additional exposure for your company.
  • Construct Concise Introductory Messages
    • Construct and send a concise introductory message to investors, including primary reasons why they should want to invest such as KPIs, expected returns, and forecasted revenue.
  • Be Proactive in Messaging Investors
    • Be proactive in messaging many investors and include a simple way for them to connect with you for a web meeting or call, such as a Calendly link.
  • Use the Activity System
    • Use the Activity system to track interested investors, and send prompt follow-up messages to investors who viewed your profile or showed interest.
  • Prepare for Due Diligence
    • Prepare for due diligence questions by interested investors and use your Business Plan and investment documents to satisfy such requests.
  • Keep Your Funding Profile Updated
    • Keep your funding profile updated with new funding raised/committed and message interested investors with any new milestones achieved.
  • Do Not Respond to Unknown Investors
    • Do not respond to or engage any parties outside of EquityNet that are not listed as approved investors (this may happen due to your public profile and LinkedIn connections).